［1］Waldmann TA, Steinfeld JL, Dutcher TF, Davidson JD, Gordon RS Jr. The role of the gastrointestinal system in "idiopathic hypoproteinemia"［J］. Gastroenterology, 1961, 41: 197-207.

［2］厉有名，张冰凌.小肠淋巴管扩张症的研究现状［J］. 诊断学理论与实践，2008，7(1):9-11.

［3］Vignes S, Carcelain G. Increased surface receptor Fas (CD95) levels on CD4+ lymphocytes in patients with primary intestinal lymphangiectasia［J］. Scand Gastroenterol, 2009, 44(2): 252-256.

［4］Wen J, Tang Q, Wu J, Wang Y, Cai W. Primary intestinal lymphangiectasia: four case reports and a review of the literature［J］. Dig Dis Sci, 2010, 55(12): 3466-3472.

［5］MacLean JE, Cohen E, Weinstein M. Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy［J］. Pediatrics, 2002, 109(6): 1177-1180.

［6］Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann's disease)［J］. Orphanet Rare Dis, 2008, 3: 5.

［7］Holzknecht N, Helmberger T, Beuers U, Rust C, Wiebecke B, Reiser M. Cross-sectional imaging findings in congenital intestinal lymphangiectasia［J］.J Comput Assist Tomogr, 2002, 26(4): 526-528.

［8］Mazzie JP, Maslin PI, Moy L, Price AP, Katz DS. Congenital intestinal lymphangiectasia: CT demonstration in a young child［J］. Clin Imaging, 2003, 27(5): 330-332.

［9］王玉环，黄瑛，梁英杰. 原发性肠淋巴管扩张症2例并文献复习［J］.中国循证儿科杂志, 2007,2(6):434-437.

［10］Rivet C, Lapalus MG, Dumortier J, Gall CL, Budin C, Bouvier R, et al. Use of capsule endoscopy in children with primary intestinal lymphangiectasia［J］. Gastrointest Endosc, 2006, 64(4): 649-650.

［11］Desai AP, Guvenc BH, Carachi R. Evidence for medium chain triglycerides in the treatment of primary intestinal lymphangiectasia［J］. Eur J Pediatr Surg, 2009, 19(4):241-245.

［12］陈晓英,陆亚红,田亚娣.2例原发性肠淋巴管扩张症患儿的护理［J］. 中华护理杂志, 2008,43(8):720-722.

［13］Kim NR, Lee SK, Suh YL. Primary intestinal lymphangiectasia successfully treated by segmental resections of small bowel［J］. J Pediatr Surg, 2009, 44(10): e13-e17.